Cargando…
The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial Irradiation
BACKGROUND: Non-small cell lung cancer (NSCLC) patients frequently develop brain metastases (BM), even though the initial imaging with brain CT or MRI was negative. Stage III patients have the highest risk to develop BM, with an incidence of approximately 30%. BM can lead to neurocognitive disorders...
Autores principales: | Witlox, Willem J. A., Ramaekers, Bram L. T., Zindler, Jaap D., Eekers, Daniëlle B. P., van Loon, Judith G. M., Hendriks, Lizza E. L., Dingemans, Anne-Marie C., De Ruysscher, Dirk K. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070634/ https://www.ncbi.nlm.nih.gov/pubmed/30094224 http://dx.doi.org/10.3389/fonc.2018.00241 |
Ejemplares similares
-
Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675)
por: Albers, Elaine A.C., et al.
Publicado: (2023) -
Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zeng, Haiyan, et al.
Publicado: (2022) -
Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions
por: Hartgerink, Dianne, et al.
Publicado: (2018) -
Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
por: Hendriks, Lizza E. L., et al.
Publicado: (2018) -
Prophylactic cranial irradiation (PCI) in locally advanced non-small cell lung cancer: time for hope?
por: De Ruysscher, Dirk K., et al.
Publicado: (2018)